10/29/2017
https://www.congress.gov...
"I agree with you that the primary responsibility is with drug manufacturers and their profit motives."
"The rebate systems seem to be leading to the wrong types of incentives."
"It seems to me that the PBMs have ignored this issue, and in some cases have made it worse."
"I believe this is an industry that is going in the wrong direction, and that is having a big impact on the prices that Americans pay at pharmacy counters from one end of the country to another."